Azenta, Inc. (AZTA)
USD 26.59
(-8.63%)
USD 26.59
(-8.63%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 128.19 Million USD | 49.86% |
| 2022 | 85.54 Million USD | 41.63% |
| 2021 | 60.39 Million USD | -47.4% |
| 2020 | 114.83 Million USD | 15.47% |
| 2019 | 99.44 Million USD | 2.54% |
| 2018 | 96.98 Million USD | -8.84% |
| 2017 | 106.39 Million USD | 14.93% |
| 2016 | 92.57 Million USD | -8.0% |
| 2015 | 100.61 Million USD | 7.54% |
| 2014 | 93.56 Million USD | -4.25% |
| 2013 | 97.71 Million USD | -5.11% |
| 2012 | 102.98 Million USD | -4.34% |
| 2011 | 107.65 Million USD | -7.02% |
| 2010 | 115.78 Million USD | 36.64% |
| 2009 | 84.73 Million USD | -19.98% |
| 2008 | 105.9 Million USD | 1.06% |
| 2007 | 104.79 Million USD | 4.95% |
| 2006 | 99.85 Million USD | 106.17% |
| 2005 | 48.43 Million USD | -32.63% |
| 2004 | 71.89 Million USD | 35.1% |
| 2003 | 53.21 Million USD | -31.95% |
| 2002 | 78.19 Million USD | 58.62% |
| 2001 | 49.29 Million USD | -13.48% |
| 2000 | 56.97 Million USD | 97.15% |
| 1999 | 28.9 Million USD | 47.45% |
| 1998 | 19.6 Million USD | -15.88% |
| 1997 | 23.3 Million USD | 30.9% |
| 1996 | 17.8 Million USD | 43.55% |
| 1995 | 12.4 Million USD | 195.24% |
| 1994 | 4.2 Million USD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q3 | 115.27 Million USD | -5.79% |
| 2024 Q2 | 122.35 Million USD | -3.8% |
| 2024 Q1 | 127.18 Million USD | -0.79% |
| 2023 Q1 | 145.93 Million USD | 70.6% |
| 2023 Q4 | 128.19 Million USD | -9.78% |
| 2023 Q2 | 150.72 Million USD | 3.28% |
| 2023 Q3 | 142.1 Million USD | -5.72% |
| 2023 FY | 128.19 Million USD | 49.86% |
| 2022 Q4 | 85.54 Million USD | 5.33% |
| 2022 FY | 85.54 Million USD | 41.63% |
| 2022 Q1 | 70.14 Million USD | 16.13% |
| 2022 Q2 | 77.75 Million USD | 10.85% |
| 2022 Q3 | 81.21 Million USD | 4.45% |
| 2021 Q4 | 60.39 Million USD | -60.96% |
| 2021 Q1 | 123.91 Million USD | 7.91% |
| 2021 FY | 60.39 Million USD | -47.4% |
| 2021 Q2 | 127.98 Million USD | 3.28% |
| 2021 Q3 | 154.72 Million USD | 20.89% |
| 2020 Q1 | 105.18 Million USD | 5.77% |
| 2020 Q2 | 107.69 Million USD | 2.39% |
| 2020 Q3 | 117.68 Million USD | 9.27% |
| 2020 Q4 | 114.83 Million USD | -2.42% |
| 2020 FY | 114.83 Million USD | 15.47% |
| 2019 Q1 | 110.07 Million USD | 13.49% |
| 2019 Q4 | 99.44 Million USD | -5.1% |
| 2019 FY | 99.44 Million USD | 2.54% |
| 2019 Q3 | 104.78 Million USD | -3.43% |
| 2019 Q2 | 108.51 Million USD | -1.42% |
| 2018 Q1 | 115.03 Million USD | 8.12% |
| 2018 FY | 96.98 Million USD | -8.84% |
| 2018 Q4 | 96.98 Million USD | -26.69% |
| 2018 Q3 | 132.29 Million USD | 4.51% |
| 2018 Q2 | 126.59 Million USD | 10.05% |
| 2017 Q4 | 106.39 Million USD | 1.04% |
| 2017 FY | 106.39 Million USD | 14.93% |
| 2017 Q1 | 92.51 Million USD | -0.06% |
| 2017 Q2 | 99.1 Million USD | 7.12% |
| 2017 Q3 | 105.3 Million USD | 6.26% |
| 2016 Q2 | 100.73 Million USD | 0.84% |
| 2016 Q4 | 92.57 Million USD | -5.69% |
| 2016 FY | 92.57 Million USD | -8.0% |
| 2016 Q1 | 99.89 Million USD | -0.72% |
| 2016 Q3 | 98.15 Million USD | -2.56% |
| 2015 Q1 | 94.93 Million USD | 1.46% |
| 2015 Q2 | 90.55 Million USD | -4.61% |
| 2015 Q3 | 95.16 Million USD | 5.09% |
| 2015 Q4 | 100.61 Million USD | 5.73% |
| 2015 FY | 100.61 Million USD | 7.54% |
| 2014 FY | 93.56 Million USD | -4.25% |
| 2014 Q4 | 93.56 Million USD | -9.22% |
| 2014 Q1 | 96.7 Million USD | -1.04% |
| 2014 Q2 | 93.75 Million USD | -3.05% |
| 2014 Q3 | 103.06 Million USD | 9.94% |
| 2013 Q3 | 92.8 Million USD | -3.93% |
| 2013 Q2 | 96.6 Million USD | -8.11% |
| 2013 Q1 | 105.12 Million USD | 2.08% |
| 2013 FY | 97.71 Million USD | -5.11% |
| 2013 Q4 | 97.71 Million USD | 5.3% |
| 2012 Q1 | 102.61 Million USD | -4.68% |
| 2012 Q2 | 105.06 Million USD | 2.39% |
| 2012 Q3 | 106.81 Million USD | 1.67% |
| 2012 Q4 | 102.98 Million USD | -3.59% |
| 2012 FY | 102.98 Million USD | -4.34% |
| 2011 Q1 | 127.14 Million USD | 9.81% |
| 2011 FY | 107.65 Million USD | -7.02% |
| 2011 Q3 | 93.52 Million USD | -26.13% |
| 2011 Q2 | 126.61 Million USD | -0.42% |
| 2011 Q4 | 107.65 Million USD | 15.11% |
| 2010 Q1 | 89.76 Million USD | 5.93% |
| 2010 FY | 115.78 Million USD | 36.64% |
| 2010 Q4 | 115.78 Million USD | -0.95% |
| 2010 Q3 | 116.89 Million USD | 12.91% |
| 2010 Q2 | 103.52 Million USD | 15.33% |
| 2009 FY | 84.73 Million USD | -19.98% |
| 2009 Q1 | 109.55 Million USD | 3.45% |
| 2009 Q2 | 98.51 Million USD | -10.08% |
| 2009 Q3 | 91.4 Million USD | -7.22% |
| 2009 Q4 | 84.73 Million USD | -7.29% |
| 2008 Q1 | 107.15 Million USD | 2.25% |
| 2008 Q2 | 113.3 Million USD | 5.74% |
| 2008 Q3 | 111.15 Million USD | -1.9% |
| 2008 Q4 | 105.9 Million USD | -4.73% |
| 2008 FY | 105.9 Million USD | 1.06% |
| 2007 Q2 | 104.82 Million USD | -0.65% |
| 2007 Q1 | 105.5 Million USD | 5.66% |
| 2007 FY | 104.79 Million USD | 4.95% |
| 2007 Q4 | 104.79 Million USD | -2.72% |
| 2007 Q3 | 107.72 Million USD | 2.77% |
| 2006 Q4 | 99.85 Million USD | 6.91% |
| 2006 Q2 | 79.27 Million USD | 1.56% |
| 2006 Q1 | 78.05 Million USD | 61.16% |
| 2006 FY | 99.85 Million USD | 106.17% |
| 2006 Q3 | 93.4 Million USD | 17.82% |
| 2005 Q1 | 72.66 Million USD | 1.08% |
| 2005 Q2 | 63.64 Million USD | -12.42% |
| 2005 Q3 | 57.7 Million USD | -9.32% |
| 2005 FY | 48.43 Million USD | -32.63% |
| 2005 Q4 | 48.43 Million USD | -16.07% |
| 2004 Q2 | 80.44 Million USD | 26.8% |
| 2004 Q4 | 71.89 Million USD | -7.28% |
| 2004 Q3 | 77.53 Million USD | -3.62% |
| 2004 FY | 71.89 Million USD | 35.1% |
| 2004 Q1 | 63.44 Million USD | 19.23% |
| 2003 Q3 | 58.17 Million USD | -13.62% |
| 2003 FY | 53.21 Million USD | -31.95% |
| 2003 Q4 | 53.21 Million USD | -8.54% |
| 2003 Q2 | 67.35 Million USD | -12.95% |
| 2003 Q1 | 77.37 Million USD | -1.05% |
| 2002 Q2 | 51.7 Million USD | -5.04% |
| 2002 Q1 | 54.45 Million USD | 10.46% |
| 2002 Q3 | 88.03 Million USD | 70.27% |
| 2002 Q4 | 78.19 Million USD | -11.18% |
| 2002 FY | 78.19 Million USD | 58.62% |
| 2001 Q3 | 65.1 Million USD | -7.78% |
| 2001 Q4 | 49.29 Million USD | -24.29% |
| 2001 Q2 | 70.59 Million USD | 8.99% |
| 2001 Q1 | 64.77 Million USD | 13.68% |
| 2001 FY | 49.29 Million USD | -13.48% |
| 2000 Q2 | 36.45 Million USD | 21.52% |
| 2000 FY | 56.97 Million USD | 97.15% |
| 2000 Q1 | 30 Million USD | 3.81% |
| 2000 Q4 | 56.97 Million USD | 6.59% |
| 2000 Q3 | 53.45 Million USD | 46.63% |
| 1999 Q2 | 16.8 Million USD | -2.33% |
| 1999 Q1 | 17.2 Million USD | -12.24% |
| 1999 FY | 28.9 Million USD | 47.45% |
| 1999 Q4 | 28.9 Million USD | 51.31% |
| 1999 Q3 | 19.1 Million USD | 13.69% |
| 1998 Q4 | 19.6 Million USD | -17.3% |
| 1998 Q1 | 26 Million USD | 11.59% |
| 1998 FY | 19.6 Million USD | -15.88% |
| 1998 Q2 | 26.7 Million USD | 2.69% |
| 1998 Q3 | 23.7 Million USD | -11.24% |
| 1997 Q3 | 21 Million USD | 14.75% |
| 1997 Q2 | 18.3 Million USD | 7.65% |
| 1997 FY | 23.3 Million USD | 30.9% |
| 1997 Q1 | 17 Million USD | -4.49% |
| 1997 Q4 | 23.3 Million USD | 10.95% |
| 1996 FY | 17.8 Million USD | 43.55% |
| 1996 Q2 | 19.4 Million USD | 0.0% |
| 1996 Q4 | 17.8 Million USD | -6.81% |
| 1996 Q3 | 19.1 Million USD | -1.55% |
| 1995 Q4 | 12.4 Million USD | 0.0% |
| 1995 FY | 12.4 Million USD | 195.24% |
| 1994 FY | 4.2 Million USD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 17.87 Million USD | -617.111% |
| AngioDynamics, Inc. | 60.61 Million USD | -111.492% |
| AtriCure, Inc. | 67.89 Million USD | -88.812% |
| Avinger, Inc. | 5.29 Million USD | -2319.743% |
| BioLife Solutions, Inc. | 43.45 Million USD | -195.006% |
| The Cooper Companies, Inc. | 735.6 Million USD | 82.572% |
| Daxor Corporation | - USD | -Infinity% |
| Ekso Bionics Holdings, Inc. | 5.05 Million USD | -2438.574% |
| Femasys Inc. | 667.11 Thousand USD | -19116.69% |
| GlucoTrack, Inc. | - USD | -Infinity% |
| Harvard Bioscience, Inc. | 24.71 Million USD | -418.684% |
| Hologic, Inc. | 679.8 Million USD | 81.142% |
| ICU Medical, Inc. | 709.36 Million USD | 81.928% |
| Intuitive Surgical, Inc. | 1.22 Billion USD | 89.497% |
| KORU Medical Systems, Inc. | 3.48 Million USD | -3582.474% |
| LeMaitre Vascular, Inc. | 52.33 Million USD | -144.966% |
| Innovative Eyewear, Inc. | 856.75 Thousand USD | -14863.134% |
| Innovative Eyewear, Inc. | 856.75 Thousand USD | -14863.134% |
| Masimo Corporation | 545 Million USD | 76.477% |
| Microbot Medical Inc. | - USD | -Infinity% |
| Meihua International Medical Technologies Co., Ltd. | 1.61 Million USD | -7827.036% |
| Merit Medical Systems, Inc. | 303.87 Million USD | 57.812% |
| Nephros, Inc. | 2.47 Million USD | -5090.202% |
| NovoCure Limited | 38.15 Million USD | -236.019% |
| NEXGEL, Inc. | 1.31 Million USD | -9619.333% |
| NEXGEL, Inc. | 1.31 Million USD | -9619.333% |
| Singular Genomics Systems, Inc. | 13.57 Million USD | -844.577% |
| OraSure Technologies, Inc. | 47.61 Million USD | -169.244% |
| Pro-Dex, Inc. | 15.26 Million USD | -739.597% |
| Pulse Biosciences, Inc. | - USD | -Infinity% |
| Predictive Oncology Inc. | 494.37 Thousand USD | -25831.38% |
| Precision Optics Corporation, Inc. | 2.86 Million USD | -4369.788% |
| QuidelOrtho Corporation | 577.8 Million USD | 77.813% |
| Repligen Corporation | 202.32 Million USD | 36.636% |
| Sanara MedTech Inc. | 4.71 Million USD | -2617.48% |
| STAAR Surgical Company | 35.13 Million USD | -264.925% |
| Sharps Technology, Inc. | 1.7 Million USD | -7400.753% |
| Utah Medical Products, Inc. | 9.58 Million USD | -1237.904% |
| DENTSPLY SIRONA Inc. | 624 Million USD | 79.455% |
| Jin Medical International Ltd. | 5.05 Million USD | -2436.999% |